AmacaThera

📍 Toronto, Canada🗓 Founded 2016👥 16 employees💰 Last funded Jan 2021
Biotechnology🌐 amacathera.ca
Website LinkedIn
AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications. Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals. We have developed a platform technology which addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas.  Currently, we have developed a combination product for post-operative pain, which is our company's lead project.
3
Total investors
0
Early stage
3
Mid stage
0
Late stage
2016
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
2
Spain
1
Investor activity2019–2021 · investors recorded per year
2019220211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in AmacaThera?
AmacaThera has 3 investors on record on gritt.io, 3 mid-stage.
When did AmacaThera last raise funding?
The most recent investment in AmacaThera recorded on gritt.io was in January 2021.
When was AmacaThera founded?
AmacaThera was founded in 2016.
What industry is AmacaThera in?
AmacaThera operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is AmacaThera based?
AmacaThera is headquartered in Toronto, Canada.